Chemesis International Inc. (CNSX:CSI) entered into a binding Letter of Intent to acquire La Finca Interacviva-Arachna Med SAS from Erika Zalez, Rafael La Torre, Mario Francisco Sanchez and Yeny Rocio Jimenez Martinez for CAD 13.5 million on November 5, 2018. The consideration will be paid in a combination of cash and common shares of Chemesis International to be determined upon execution of the definitive agreement. All stock issued will be subject to a 36-month phased lock-up period. As on January 9, 2019, Chemesis International Inc. (CNSX:CSI) entered into a definitive agreement to acquire La Finca Interacviva-Arachna Med SAS. Closing of the transactions contemplated by the LOI are subject to regulatory approval. Chemesis International Inc. (CNSX:CSI) completed the acquisition of La Finca Interacviva-Arachna Med SAS from Erika Zalez, Rafael La Torre, Mario Francisco Sanchez and Yeny Rocio Jimenez for CAD 16.8 million on January 9, 2019. As per the terms, Chemesis International Inc. will issue 7.48 million shares and will pay CAD 5.5 million within the next 24 months. The stock issued is subject to 36-month contractual escrow agreement.